Generali Investments Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61M Buy
9,966
+1,468
+17% +$503K 0.78% 27
2026
Q1
$2.99M Sell
8,498
-361
-4% -$129K 0.7% 29
2025
Q4
$2.9M Buy
8,859
+1,196
+16% +$379K 0.58% 42
2025
Q3
$2.16M Buy
7,663
+1,471
+24% +$427K 0.45% 49
2025
Q2
$1.73M Sell
6,192
-295
-5% -$83.6K 0.39% 63
2025
Q1
$2.02M Buy
6,487
+83
+1% +$24.5K 0.57% 46
2024
Q4
$1.67M Buy
+6,404
New +$1.9M 0.43% 55

Other funds holding AMGN

Generali Investments Management's AMGN Position: Q2 2026 in Review

Generali Investments Management increased its Amgen (AMGN) stake by 17% in Q2 2026, buying an estimated $503K and bringing the position to 9,966 shares worth $3.61M. The position accounts for 0.78% of the portfolio, ranked #27.

Generali Investments Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Generali Investments Management held 9,966 shares of Amgen worth $3.61M as of Q2 2026.
  • Generali Investments Management bought 1,468 Amgen shares in Q2 2026, an estimated $503K.
  • Amgen made up 0.78% of Generali Investments Management's portfolio in Q2 2026, its #27 holding.
  • Generali Investments Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.